Cytek Biosciences, Inc. (CTKB)
NASDAQ · Healthcare
Cytek Biosciences, Inc. Cash Flow 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Operating Cash Flow | -4.7M | 25.4M | 5.3M | -12.2M | 4.6M | 15.2M |
| Depreciation & Amort. | 7.6M | 7.2M | 6.0M | 2.5M | 1.2M | 603,000 |
| Investing Activities | ||||||
| Capital Expenditure | 4.1M | 3.5M | 4.6M | 9.7M | 4.4M | 1.5M |
| Free Cash Flow | -8.8M | 21.9M | 633,000 | -22.0M | 266,000 | 13.6M |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Buybacks | 15.1M | 21.6M | 44.2M | 0 | 0 | — |
Cytek Biosciences, Inc. Cash Flow — FAQ
Cytek Biosciences, Inc. (CTKB) cash flow over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CTKB's cash flow history?
The chart and table above show Cytek Biosciences, Inc.'s cash flow by year and by quarter, including the growth rate.